Brentuximab vedotin treatment associated with acute and chronic inflammatory demyelinating polyradiculoneuropathies

J Neurol Neurosurg Psychiatry. 2020 Jul;91(7):786-788. doi: 10.1136/jnnp-2020-323124. Epub 2020 Apr 23.
No abstract available

Keywords: haematology; neuromuscular; neuropathy; neurophysiology; oncology.

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents / adverse effects*
  • Antineoplastic Agents / therapeutic use
  • Brentuximab Vedotin / adverse effects*
  • Brentuximab Vedotin / therapeutic use
  • Female
  • Guillain-Barre Syndrome / chemically induced*
  • Hodgkin Disease / drug therapy
  • Humans
  • Lymphoma, Non-Hodgkin / drug therapy
  • Male
  • Middle Aged
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating / chemically induced*
  • Young Adult

Substances

  • Antineoplastic Agents
  • Brentuximab Vedotin